BC-DXI-843

• Description:

  BC-DXI-843 is inhibitor of AIMP2-DX2, and is potential for development of novel therapeutics targeting AIMP2-DX2 in lung cancer.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  546.66

• Molecular Formula:

  C28H26N4O4S2

• Notes:

  Research use only, not for human use.

• Receptor:

  AIMP2-DX2

• CAS Number:

  2421117-98-6